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Abstract
B-cell leukemia/lymphoma 11B (Bcl11b) is a transcription factor showing predominant expression in the striatum. To date,
there are no known gene targets of Bcl11b in the nervous system. Here, we define targets for Bcl11b in striatal cells by
performing chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in combination with
genome-wide expression profiling. Transcriptome-wide analysis revealed that 694 genes were significantly altered in striatal
cells over-expressing Bcl11b, including genes showing striatal-enriched expression similar to Bcl11b. ChIP-seq analysis
demonstrated that Bcl11b bound a mixture of coding and non-coding sequences that were within 10 kb of the
transcription start site of an annotated gene. Integrating all ChIP-seq hits with the microarray expression data, 248 direct
targets of Bcl11b were identified. Functional analysis on the integrated gene target list identified several zinc-finger
encoding genes as Bcl11b targets, and further revealed a significant association of Bcl11b to brain-derived neurotrophic
factor/neurotrophin signaling. Analysis of ChIP-seq binding regions revealed significant consensus DNA binding motifs for
Bcl11b. These data implicate Bcl11b as a novel regulator of the BDNF signaling pathway, which is disrupted in many
neurological disorders. Specific targeting of the Bcl11b-DNA interaction could represent a novel therapeutic approach to
lowering BDNF signaling specifically in striatal cells.
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Introduction
The striatum plays crucial roles in the planning and modulation
of movement and motor function, stereotyped behavior and the
establishment of habits [1–3], as well as being associated with
cognitive function and motivation-related behavior [4]. Precise
regulation of gene expression in the striatum is essential to these
functions; accordingly, disruption of this regulation can have
detrimental consequences, resulting in the development of severe
movement disorders and psychiatric conditions, many of which
have been previously associated with transcriptional dysregulation.
Understanding of factors that control striatal gene expression in
mature tissues has paramount relevance to the pathology of
disorders associated with these disorders.
Transcriptional regulation in the striatum has primarily focused
on the development and differentiation of medium spiny neurons,
which make up ,90% of the neurons in the striatum. The
transcription factor, B-cell leukemia/lymphoma 11B (Bcl11b)
(a.k.a. chicken ovalbumin upstream promoter transcription factor
interacting protein 2, CTIP2), which is predominantly expressed
in striatal medium spiny neurons, plays an important role in
striatal development [5]. However, we, and others, have
demonstrated abundant striatal-enriched expression of Bcl11b in
adulthood [5–7] (see Figure S1), suggesting that it plays important
roles in controlling the expression of genes necessary to the
functioning and maintenance of mature medium spiny neurons.
Although Bcl11b has been shown to play critical roles in T-cell
function and maintenance [8], its functional role in the adult brain
is unknown.
Here we have used genome-scale chromatin immunoprecipita-
tion followed by massively parallel sequencing (ChIP-Seq) in
combination with genome-wide transcriptome analysis to identify
and characterize Bcl11b target genes in striatal cells. Our findings
reveal a large set of Bcl11b target genes in striatal cells, providing
the first insight into core striatal gene regulation. We further
identify a novel consensus binding motif for Bcl11b to account for
direct Bcl11b-DNA binding. Importantly, we find that top Bcl11b
target genes encode numerous components of the brain-derived
neurotrophic factor (BDNF) signaling pathway. Altered BDNF
signaling has been implicated in several neurodegenerative
diseases, including Huntington’s, Alzheimer’s and Parkinson’s
diseases [9] and relevant therapeutic strategies for these disorders
are aimed at increasing BDNF levels in the brain [10,11]. We
suggest that the design of small molecules to specifically interfere
with Bcl11b-DNA interactions may represent a feasible therapeu-
tic approach to elevate BDNF signaling.
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Striatal cell milieu
In order to identify candidate target genes for Bcl11b expression
regulation, we analyzed transcriptome-wide expression profiles of
wild-type, immortalized, striatal cells (STHdh striatal cells [12])
overexpressing Bcl11b. Because STHdh cells were derived from
striata of embryonic day 14 tissue, we first tested whether wt
STHdh striatal cells express markers of mature striatal neurons, as
well as other striatal-enriched genes randomly selected from our
previous studies [6], by standard PCR analysis. We find that
STHdh cells express Ppp1r1b, encoding DARPP-32, the classic
marker for mature medium spiny neurons, as well as mRNAs for
other striatal markers, including neuronal guanine exchange factor
(Ngef), brain-specific angiogenesis inhibitor 1-associated protein 2
(Baiap2), diacylglycerol kinase, epsilon (Dgke), regulator of G
protein signaling 9 (Rgs9), copine V (CpneV), G protein, gamma
7 subunit (Gng7), adenylate cyclase 5 (Adcy5), Forkhead box protein
P1 (Foxp1) and Bcl11b itself (Figure S2), suggesting that they share
to some extent a similar molecular environment as in vivo medium
spiny neurons.
Identification of Bcl11b target genes by microarray
analysis
We performed microarray analysis using the Illumina Array
MouseRef-8 v2 chips on Bcl11b- transfected striatal cells and
found 694 genes (256 upregulated and 436 downregulated) whose
expression was significantly altered by Bcl11b (at p,0.0027;
FDR,0.10); these gene expression changes are depicted in
Figure 1A. Complete lists of genes differentially expressed in
Bcl11b- transfected striatal cells compared to untransfected cells
are provided in Table S1. We validated the Bcl11b-induced
expression changes of selected genes by real-time PCR analysis.
These included FBJ osteosarcoma oncogene (Fos), Follistatin (Fst),
Brain-specific angiogenesis inhibitor 1-associated protein 2
(Baiap2), Ras homolog gene family, member Q (Rhoq), Serum
response factor (Srf) and Brain-derived neurotrophic factor (Bdnf)
(Figure 1B).
Given that Bcl11b shows enriched expression in the striatum
(see Figure S1), we searched for other striatal-enriched genes in
our microarray datasets. From a list of 64 striatal-enriched genes,
determined from our previous studies [6], nearly one-third (n=18)
were significantly altered in their expression in Bcl11b-transfected
cells (p,0.05) (Table 1). This represents a statistically significant
overrepresentation of striatal-enriched genes as Bcl11b targets
compared to genes showing generalized expression throughout the
brain (Fisher’s Exact test; two-tailed; p,0.023). Notably, n=58
previously designated striatal-enriched genes gave hybridization
‘‘Present’’ calls on our microarray chips, further indicating that
these cells resemble the neuronal subtype from which they were
derived.
ChIP-Seq analysis of Bcl11b binding sites
In order to identify the genome-wide binding patterns of
Bcl11b, we performed chromatin immunoprecipitation with a
Bcl11b antibody in transfected striatal cells followed by massively
parallel sequencing of the co-immunoprecipitated genomic DNA
fragments (ChIP-Seq). We applied MACS software to identify
Bcl11b-enriched binding regions. Examples of several target genes
are shown in Figure 2. We then mapped the Bcl11b binding
regions to genes using the UCSC Genome Browser and identified
1,410 Bcl11b-significantly-enriched binding regions ranging in size
from 61–428 bp genome-wide. 232 of these genes were within
10 kb of an annotated transcriptional start site (TSS), however,
only 36 of these mapped to within 1 kb of the TSS, suggesting that
the majority of Bcl11b binding sites are far away from the
proximal promoter regions. Further annotation of the top hits
found that a majority of sequences within 10 kb of the TSS were
within an intronic region (Table S2). We also observed that a
Bcl11b ChIP peak overlaps with exon 1 of the Bcl11b gene itself,
suggesting that, like many other eukaryotic transcription factors
[13], Bcl11b regulates its own expression, as we have previously
proposed [14].
Figure 1. A. Heatmap depiction of the top 693 genes
(FDR,0.10) differentially expressed in response to Bcl11b
overexpression in striatal cells. Data are from n=4 different sets of
transfected cells. Heatmaps were generated with dChip program (www.
dChip.org). Red indicates increased and blue indicates decreased
expression relative to the mean transcript expression value. B. Real-
time PCR validation of microarray expression differences elicited by
Bcl11b in striatal cells. The genes are indicated by their official UniGene
ID. Hprt was used to normalize gene expression differences. Open bars
represent mock-transfected striatal cells, closed bars represent Bcl11b-
transfected striatal cells. Asterisks denote significant differences in
Bcl11b-transfected striatal cells compared to mock-transfected cell, as
determined by ANOVA *, p,0.05; **, p,0.01; ***, p,0.001. C. Heatmap
expression changes of genes related to the BDNF signaling pathway.
doi:10.1371/journal.pone.0023691.g001
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annotated genes using standard ChIP followed by real-time qPCR
analysis. This analysis revealed enriched binding of Bcl11b (over
IgG control) to the proximal promoter regions of several genes,
including, Sp140 nuclear body protein (Sp140), Low density
lipoprotein receptor (Ldlr), Dihydrouridine synthase 2-like (Dus2l),
Histone cluster 1, H1a (Hist1h1a), Inositol polyphosphate multi-
kinase (Ipmk), Crystallin, beta A1 (Cryba1) (Figure 3). Bcl11b
binding to these genomic regions was also detected in un-
transfected striatal cells, which endogenously express Bcl11b,
albeit at low levels.
Identification of consensus DNA-binding motifs and
potential cofactors
We searched for consensus binding motifs for Bcl11b using
MEME [15] and Motif Map [16] in the retrieved sequences of the
Bcl11b binding regions. We found several potential consensus
binding motifs and used the Bayesian Branch Length Score
(BBLS) [16] to assess their evolutionary conservation in the
multiple alignment of the mouse genomes with other genomes
from the UCSC genome browser (29). The top consensus logos
(BBLS score cutoff .1) identified in .25 separate Bcl11b binding
sequences, regardless of genomic location, are ACCACA,
TGCTTG and AGTGCT (Figure 4A). We also searched for
consensus motifs in just the Bcl11b binding regions present in the
annotated 59 region of a given gene and found additional
significant putative motifs, AG[AT]GTG and GGATCA
(Figure 4B).
We next assessed whether other TFs could bind to the Bcl11b
binding regions identified by ChIP-seq, potentially acting as
Bcl11b cooperators for the regulation of gene expression. We
searched for already annotated transcription factor motifs in
mouse from the TRANSFAC database [17]. Several motifs for
other factors, including AML1, MAFB, and HNF4, were found to
have a significant BBLS score on subsets of the top ChIP-seq
binding hits (Table 2). In addition, Bcl11b has been shown to alter
transcription in HEK293 cells by interacting with chicken
ovalbumin upstream promoter transcription factor (COUP-TF1;
Nr2f1) [18]. Searching the same ChIP-seq hits for the previously
defined COUP-TF 1 binding 6-mer (AGG/TTCA and TGTACT
[19], revealed that 32.4% of the sequences contained one of these
three sites.
Integrated analysis of Bcl11b direct targets
To identify the most probable Bcl11b target genes, we
compared the list of genes whose expression levels were altered
by Bcl11b (at p,0.05) to the complete list of gene hits showing
Bcl11b binding from the ChIP-seq assay. We obtained an
integrated list of 247 top target genes for Bcl11b (Figure S3).
Among them, 149 of the binding regions resulted in a
downregulation of gene expression, while 98 were associated with
an upregulation of gene expression (Figure S3). We asked whether
examination of the set of integrated Bcl11b target genes could
suggest potential functions for this TF in striatal neurons. We
performed functional annotation of target genes using DAVID
bioinformatics resources, which includes databases curating Gene
Ontology (GO) terms, protein-protein interactions, protein
functional domains, disease associations, and known pathways.
To reduce the redundancy of common GO screening, we used the
Functional Annotation Clustering tool, which displays similar
annotations together. Several interesting annotation clusters were
identified, including those related to calcium signaling, phosphor-
ylation and regulation of small GTPase activity and phosphory-
lation (Table S3). We also find that Bcl11b target genes include
several zinc finger–containing proteins of the C2H2 class, including
Brpf1, Klf8, Zfp41, Zfp428, Zfp 647, Bcl6b, Hivep2, Zbtb17, Trerf1,
Snai1, Zbtb4, Foxp1 and Bcl11b itself (Table S3).
We next focused on the KEGG and PANTHER pathways of the
DAVID database. A critical pathway downstream from Bcl11b in
the striatum wasrevealed to be BDNF/neurotrophinsignaling, with
Table 1. Striatal-enriched genes regulated by Bcl11b.
Gene ID: Gene Description: Fold-change: P-Value: FDR: Acc #:
Actn2 Alpha-actinin 2 1.933 0.001 0.064 NM_033268
Foxp1 Forkhead box P1 1.370 0.033 0.284 AF339103
Pde1b Phosphodiesterase 1B, Ca2+-calmodulin dependent 0.623 0.001 0.067 NM_008800
Rgs9 Regulator of G-protein signaling 9 1.478 0.043 0.476 NM_011268
Rin1 Ras and Rab interactor 1 0.654 0.001 0.047 NM_145495
Arpp19 cAMP-regulated phosphoprotein 19 0.751 0.012 0.190 NM_021548
Baiap2 BAI1-associated protein 2 0.601 0.001 0.071 NM_130862
Bcl11b B-cell leukemia/lymphoma 11B 0.665 0.018 0.374 NM_021399
Ensa Endosulfine alpha 1.374 0.003 0.105 NM_019561
Foxp2 Forkhead box P2 0.748 0.007 0.162 NM_053242
Kcnip2 Kv channel-interacting protein 2 0.657 0.036 0.296 NM_001034005
Klf16 Kruppel-like factor 16 1.590 0.007 0.148 NM_078477
Ngef Neuronal guanine nucleotide exchange factor 0.752 0.005 0.131 NM_019867
Osbpl9 Oxysterol sterol binding protein 8 0.793 0.013 0.197 NM_1754589
Pde10a Phosphodiesterase 10A 0.698 0.011 0.185 NM_011866
Rap1gap Rap1 GTPase-activating protein 1.397 0.040 0.307 NM_001081155
Rarb RAR beta receptor 1 0.552 0.006 0.140 NM_011243
Zfp521 Zinc finger protein 521 0.704 0.003 0.108 NM_145492
doi:10.1371/journal.pone.0023691.t001
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targets. These include Rps6ka5, Irak4, Plcg2, Mapk9, Shc1, Mapk10
and Rapgef1 (Table S4; Figure 5). The ErbB, or Epidermal Growth
Factor (EGF), signaling pathway also was significantly associated
with Bcl11b, with six target genes appearing in this pathway: Nrg3,
Pak4, Plcg2, Mapk9, Shc1,a n dMapk10 (Table S4). To expand the
pathways analysis, we used the entire list of Bcl11b-induced gene
expression changes as input and found that n=20 genes related to
neurotrophin signaling were altered in expression by Bcl11b, a
majority of which were downregulated in expression (Figures 1C
and Figure 5). Taken together, these data reveal that Bcl11b plays
an important role in growth factor signaling in striatal cells,
primarily acting as a negative regulator of this pathway.
Discussion
Precise regulation of gene expression in the striatum is essential
to its specific functions, which include the planning and control of
movement and motor function, as well as a variety of other
cognitive processes. Transcriptional dysregulation in striatal cells is
associated with severe movement disorders and psychiatric
conditions. Hence, a better understanding of the mechanisms of
gene expression regulation in adult striatum is essential. The
transcription factor, Bcl11b, is a C2H2 zinc finger protein, which
exhibits enriched expression in the striatum; thus we have
hypothesized that it is important in the control of striatal gene
expression, although its exact functional role has remained
unknown. In this study, we used chromatin immunoprecipitation
followed by high-throughput sequencing (ChIP-Seq) in combina-
tion with transcriptome-wide expression profiling, to identify a
large, unbiased set of Bcl11b target genes. We integrated the list of
genes whose expression levels were altered by Bcl11b to the
complete list of gene hits showing Bcl11b binding from the ChIP-
seq assay, obtaining a list of 247 direct target genes for Bcl11b
regulation. This list contains genes both up- and down-regulated
expression in response to Bcl11b. We validated these high-
Figure 2. ChIP-seq binding patterns for Bcl11b target genes Msh3, Foxp1 and Wdr41. The number of tags reflecting the ChIP enrichments is
plotted on the y axis and chromosomal coordinates are shown on the x axis. RefSeq genes are in the orientation indicated by arrows on the gene
representation. Enriched peaks have the following coordinates: Msh3 coordinates: chr13: 93085721–93085950; Foxp1 coordinates: chr6: 99112792–
99113024; Wdr41 coordinates: chr13: 95782433–95782649.
doi:10.1371/journal.pone.0023691.g002
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PCR expression assays, providing confidence in our global output
of Bcl11b target genes.
Subjecting our integrated Bcl11b gene target list to pathway
analysis, we find that Bcl11b regulates numerous genes of the
BDNF signaling pathway. Neurotrophins are a family of trophic
factors involved in the development, differentiation and survival of
CNS cells. The neurotrophin family consists of four members:
nerve growth factor (NGF), brain derived neurotrophic factor
(BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4)
(Figure 5) of which BDNF is the most widely recognized.
Neurotrophins exert their functions via activation of Trk tyrosine
kinase receptors, which are linked to various intracellular signaling
cascades, including the MAPK, PI-3 kinase and the PLC
pathways. These signals play an important role for neural
development and additional higher-order activities such as
learning and memory. Accordingly, altered activities of BDNF
and other neurotrophins have been implicated in several
neurodegenerative diseases, including Huntington’s, Alzheimer’s
and Parkinson’s diseases [9]. Therapeutic strategies aimed at
increasing BDNF levels in the brain are thought to be feasible
treatment approaches in the clinic [10,11]. We found that Bcl11b
regulates the expression of genes encoding a wide array of
components of the BDNF/neurotrophin signaling pathways,
including Bdnf itself in cultured striatal cells. A majority of
expression changes were all decreases, suggesting that Bcl11b is a
negative regulator of BDNF signaling.
While we identified 247 genes showing overlap between our
microarray and ChIP-seq datasets, this number represents only a
fraction of the total genes showing altered expression by Bcl11b
from the microarray dataset. Many of these expression alterations
are of great interest. For example, we found that nearly one-third
(n=18) of previously identified striatal-enriched genes were
significantly altered in their expression in Bcl11b-transfected cells,
indicating that Bcl11b is a central regulator of striatal-specific gene
expression. However, only one of these contained a Bcl11b
binding region, as determined by ChIP. Several reasons could
account for this apparent discrepancy. One possibility is that some
Figure 3. Chromatin-immunoprecipitation (ChIP)-qPCR for Bcl11b target genes. ChIP was performed using an anti-Bcl11b or control IgG
antibody on both mock-transfected (pcDNA3.1) (open bars) and Bcl11b-transfected (closed bars) striatal cells as described in Methods. Real-time
qPCR analysis was performed on the immunoprecipitated DNA using primers designed to amplify regulatory regions of the indicated genes.
doi:10.1371/journal.pone.0023691.g003
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effects of primary gene expression changes elicited directly by
Bcl11b. We found that Bcl11b regulates the levels of several other
TFs; hence, it is possible that differentially expressed genes are
targets of one of these other factors. Second, it is possible that the
expression regulation of some of these genes requires a cofactor,
and that protein-protein interactions of Bcl1b with a cofactor mask
the pull-down of the chromatin immunoprecipitation step. For
example, Bcl11b has been shown to alter transcription in HEK293
cells by interacting with COUP-TF family members, in particular
COUP-TF1 [18] and we found that several of the ChIP sequences
contained a known consensus binding domain for COUP-TF1.
Finally, ChIP assays have technical limitations, such as the
sensitivity of the antibody, and they may not detect transient
protein-DNA interactions.
We found a total of 1,465 Bcl11b-binding regions in the mouse
genome, however, only 232 of these mapped to within 10 kb of a
TSS and only 36 of these within 1 kb. This suggests that Bcl11b
acts distally, rather than acting at the proximal promoter regions
of genes. Bcl11b has previously been shown to bind a CTIP
response element that is related to the canonical GC box [20],
although this motif, GGCCG/AG/AAGG, was not present in any
Bcl11b binding regions in striatal cells. However, we did identify
several novel Bcl11b binding motifs, including ACCACA,
TGCTTG and AGTGCT. Additional significant motifs,
AG[AT]GTG and GGATCA, were also identified when search-
ing Bcl11b-binding sequences in the 59 regions of the genes. A
recent study examining the DNA binding domains of a large
group of TFs revealed that ,half of the TFs recognized multiple,
distinct sequence motifs, indicating flexibility in TF binding
recognition [21].
The identification of a specific Bcl11b binding motif has
potential therapeutic relevance, as it is possible to design small
molecules that target specific DNA sequences [22,23]. Synthetic
polyamides containing N-methylimidazole and N-methylpyrrole
amino acids show high affinity and specificity for predetermined
DNA sequences. In particular, previous studies have shown that
an eight-ring polyamide targeted to a specific region of the
transcription factor TFIIIA binding site can interfere with 5S
RNA gene expression in Xenopus kidney cells [22]. Identification
of the relevant DNA motif for Bcl11b binding to promoter regions
of genes in the BDNF signaling pathway could lead to the design
of similar molecules, which would represent a novel therapeutic
approach to up-regulating the BDNF pathway in striatal neurons.
Such a therapeutic approach would be applicable to several
neurodegenerative diseases, including Huntington’s, Alzheimer’s
and Parkinson’s diseases, in which decreased BDNF signaling has
been implicated [9].
One cautionary note when translating our findings into in vivo
striatum gene regulation is that the striatal cells used in this study
were immortalized from embryonic day 14 tissue. Although we
show that these cells express DARPP-32, a marker of mature
medium spiny neurons [24], as well as several other genes that are
selectively expressed in the adult striatum, it is possible that the
global gene expression profiles in these cells are different
compared to in vivo medium spiny neurons.
In summary, these findings represent the first comprehensive
genome-wide study of Bcl11b binding, and coupled with
transcriptome profiling, reveal important roles for Bcl11b in the
regulation of striatal gene expression and function. This approach
allows for the identification of potential disease-related pathways
under the controls of Bcl11b and accordingly, these findings
illuminate neurotrophin signaling pathway as a primary target
pathway for Bcl11b regulation. Therapeutic strategies aimed at
increasing BDNF levels in the brain are thought to be feasible
treatment approaches for several neurodegenerative disorders.
Our findings suggest that specific targeting of the Bcl11b/DNA
interaction represents a novel means to upregulate the BDNF
pathway. Importantly, due to the striatal-enriched expression of
Bcl11b, targeting this TF would not result in widespread effects in
other brain regions.
Materials and Methods
Striatal Cell Culture and RNA Preparation
Conditionally immortalized wild-type STHdh
Q7striatal neuronal
progenitor cells were a kind donation from Dr. Marcy MacDonald
[12]. The striatal cells were grown at 33uC in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 1% non-essential amino acids, 2 mM L-glutamine and
400 mg / m lG 4 1 8( S i g m a - A l d r i c h ,S tL o u i s ,M O ) .C e l l sw e r ep l a t e d
at 3610
5 cells per well in six well tissue culture plates. The following
Figure 4. DNA binding consensus sequences for Bcl11b. A.
Bcl11b binding motifs identified in all of the top ChIP-seq retrieved
sequences. B. Bcl11b binding motifs in sequences from the 59 regions.
doi:10.1371/journal.pone.0023691.g004
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containing the cDNA of mouse Bcl11b (beta isoform; nts 272–2710 of
accession # AB043553) using Polyjet transfection reagent (SignaGen,
Ijamsville, MD) according to the manufacturer’s instructions. Empty
expression vector, pcDNA3.1, was used to ensure all wells received the
same amount of total DNA. Transfection efficiency was assessed in
duplicate sets of transfected cells by quantifying the percentage of
green fluorescent protein (GFP)-positive cells using fluorescence
microscopy and by measuring Bcl11b mRNA expression with qPCR.
Two days after transfection, cells were harvested, and RNA was
extracted using RNAeasy mini kit (Qiagen) with DNase I treatment to
eliminate genomic DNA contamination.
Microarray Experiments
Total RNA was quantified using NanoDrop (ND-1000,
manufacturer) and quality was checked with the Agilent 2100
Bioanalyzer using the RNA 6000 Nano LabChip. One microgram
(1 mg) of total RNA was taken through Ambion’s Illumina
TotalPrep RNA Amplification System (protocol available at
http://ambion.com/techlib/prot/fm_IL1791.pdf). Post amplifica-
tion RNA (750 ng cRNA) product was hybridized onto the
Illumina Sentrix BeadChip Array MouseRef-8 v2 for 18 hours at
58uC (protocol available at http://www.illumina.com/products/
mouseref-8_expression_beadchip_kits_v2.ilmn). After hybridiza-
tion, the BeadChip Arrays were washed and stained as per
protocol requirements. BeadChip Arrays were scanned using the
Illumina BeadArray Reader with default settings. Data normali-
zation was performed using GenomeStudio Gene Expression
Module v1.0 with quantile normalization [25,26]. The sample
clustering was done using BRB-ArrayTools (http://linus.nci.nih.
gov/BRB-ArrayTools.html), with centered correlation and aver-
age linkage. The Limma package in the R software was used to
Table 2. TRANSFAC mouse motifs.
Motif ID: Motif Name: Motif: #: Genes:
M01658 AML1 TGTGGTT 13 Cdh23 Ddx28 FoxP1 Id3 Ipmk Mocos Msh3 Rundc3b Sh3rf3 Sp140 Tmx4 Trpm8 Wdr41
M00751 AML1 TGTGGT 13 Cdh23 Ddx28 FoxP1 Id3 Ipmk Mocos Msh3 Rundc3b Sh3rf3 Sp140 Tmx4 Trpm8 Wdr41
M01227 MAFB GCTGAC 12 Cdh23 Cisd1 FoxP1 HIST1h1a Id3 Msh3 Rlf Sh3rf3 Sp110 Trpm8 Ubtd1 Wdr41
M01033 HNF4 GGGGCA 11 Bcl11b Cdh23 FoxP1 HIST1h4a Id3 Ipmk Odz2 Sh3rf3 Sp140 Ubtd1 Uhrf1bp1
M01268 FXR AGGTCAT 10 Bcl11b Cdh23 Cisd1 FoxP1 HIST1h4a Ipmk Mocos Sh3rf3 Ubtd1 Uhrf1bp1
M01181 Nkx3-2 TAAGTG 10 Bcl11b Cdh23 Ddx28 FoxP1 Ipmk Msh3 Odz2 Rlf Sp140 Uhrf1bp1
MA0078 Sox17 CCCATTGTC 9 Adamts6 Cisd1 Ipmk Mocos Msh3 Sh3rf3 Tmx4 Trpm8 Ubtd1
M01282 PPARA TGACCTC 9 Cdh23 Cisd1 FoxP1 Rapgef1 Sh3rf3 Trpm8 Ubtd1 Uhrf1bp1 Wdr41
M01270 PPARG AGGTCAG 9 Bcl11b Cdh23 FoxP1 HIST1h4a Ipmk Mocos Msh3 Odz2 Sh3rf3
M01104 MOVO-B GCGGGGG 9 Bcl11b Cdh23 Chd6 Cisd1 FoxP1 Id3 Sh3rf3 Ubtd1 Uhrf1bp1
M01269 NURR1 TGGCCTT 8 Cisd1 FoxP1 Id3 Ipmk Rapgef1 Sh3rf3 Trpm8 Uhrf1bp1
M01032 HNF4 AGGTCA 8 Bcl11b Cdh23 HIST1h4a Ipmk Odz2 Rlf Sh3rf3 Ubtd1
M00921 GR TCTGTTCT 8 Bcl11b Dus2l Ipmk Mocos Msh3 Rapgef1 Rundc3b Wdr41
M00240 Nkx2-5 TCAAGTG 8 Bcl11b Chd6 Id3 Ipmk Odz2 Rapgef1 Sh3rf3 Uhrf1bp1
M01709 MAFA TCAGCAG 7 FoxP1 HIST1h4a Id3 Mocos Msh3 Odz2 Sh3rf3
M01118 WT1 CCCCCCCCC 7 Cisd1 Id3 Ipmk Sh3rf3 Trpm8 Ubtd1 Wdr41
M00726 USF2 CACGTG 7 Bcl11b Cdh23 Chd6 Ddx28 Mocos Sh3rf3 Wdr41
M00468 AP-2rep CAGTGGG 7 Chd6 FoxP1 Id3 Ipmk Mocos Msh3 Sh3rf3
MA0122 Nkx3-2 CTAAGTGGC 6 Bcl11b Cdh23 FoxP1 Msh3 Odz2 Uhrf1bp1
MA0067 Pax2 AGTCACGC 6 Bcl11b Chd6 Id3 Odz2 Tmx4 Ubtd1
M01287 Neuro CAGCTG 6 Cdh23 FoxP1 Id3 Mocos Msh3 Sh3rf3
M01243 MTF1 TGCGCAC 6 FoxP1 Msh3 Sh3rf3 Ubtd1 Uhrf1bp1 Wdr41
M00801 CREB CGTCAC 6 Chd6 HIST1h4a Lcor Mocos Sh3rf3 Ubtd1
M00499 STAT5A CACTTCTC 6 Cisd1 Id3 Lcor Odz2 Sp140 Trpm8
M01721 PUR1 GGGCCAGGG 5 Cdh23 Chd6 FoxP1 Sh3rf3 Sp140
M01694 YY2 CCATTAC 5 Adamts6 Cdh23 Id3 Msh3 Wdr41
M01665 IRF8 AGTTTCA 5 HIST1h4a Ipmk Lcor Sh3rf3 Zfp474
M00963 T3R CCTGTCCTT 5 Rapgef1 Sh3rf3 Trpm8 Ubtd1 Uhrf1bp1
M00913 MYB CAACTGCCC 5 Cdh23 FoxP1 Ipmk Trpm8 Ubtd1
M00712 myogenin GGCAGCTG 5 Cdh23 FoxP1 Id3 Msh3 Sh3rf3
M00492 STAT1 CACTTCCG 5 Adamts6 Ipmk Lcor Trpm8 Ubtd1
M00272 p53 AGGCATGCCC 5 Bcl11b FoxP1 Rapgef1 Sh3rf3 Ubtd1
M00159 C/EBP TGTGTGGTAAGGC 5 FoxP1 Ipmk Mocos Sp140 Wdr41
P-value cut-off,0.001 and BBLS cut-off.1.
doi:10.1371/journal.pone.0023691.t002
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Bcl11b overexpression [27]. This microarray data has been
deposited in the NCBI GEO database with Accession #
GSE31096. Results are presented as a fold change in expression
level with an absolute 1.25-fold change cut-off, and p-value,0.05
(see Table S1).
Chromatin Immunoprecipitation (ChIP)
ChIP assays on cultured striatal cells were performed as
described in previous studies [28]. Briefly, cellular homogenates
were cross-linked by incubating with 1% of formaldehyde for
15 min at room temperature, and then homogenizing to isolate
nuclei. DNA was to achieve ,0.2–1.0 kb sized DNA fragments.
An aliquot of precleared homogenates was incubated with 2 mgo f
rabbit anti-Bcl11b antibody (Bethyl Laboratories, Montgomery,
TX) or 3 mg of control IgG (BD Biosciences) overnight at 4uC,
followed by hybridization to 60 ml of protein-sepharose A beads.
The protein-DNA complexes were washed on the beads, elution
buffer added and the eluate incubated with proteinase K to digest
protein. The cross-linking reaction was reversed by incubating at
65uC overnight and DNA was purified with DNA purification kit
(ZYMO research Corp). The recovered pull-down DNA, as well
as input DNA, was used for massively parallel sequencing (ChIP-
seq below) or quantified by real-time PCR analysis for ChIP-PCR.
Chromatin-immunoprecipitation-sequencing (ChIP-seq)
ChIP-seq sequencing libraries were prepared using 10 ng of
DNA prepared by ChIP above (pull-down and input). ChIP DNA
samples ends were repaired and DNA products were purified
using DNA Clean&Concentrator
TM-5 Kit (Zymo Research,
Irvine, CA). Next, DNA ends were A-tailed and again purified
using the DNA Clean&Concentrator
TM-5 Kit. Illumina Paired
End-adapter oligonucleotides (0.33 mM) were then ligated to the
A-tailed cDNA ends and purified as before. The DNA library
products were separated on an Invitrogen 2% Size-Select agarose
gels and products corresponding to a size of approximately 200–
250 bases were removed from the gel and cleaned using the
Agencourt SPRI system. The DNA material was PCR amplified
and purified on 2% NuSieve GTGH agarose gel, excised, and
isolated again using Zymoclean
TMGel DNA recovery kit. The
purified DNA library was quantified using the Qubit quantifica-
tion platform (Invitrogen, Carlsbad, CA) and sized using the 2100
Bioanalyzer. DNA products were then denatured in 0.1 N NaOH
and diluted to a final concentration of 10 pM before being loaded
onto the Illumina paired-end flow-cell for massively parallel
sequencing by synthesis on the Illumina GAIIx.
The Genome Analyzer Pipeline Software v1.7 was used to
perform the early data analysis of a sequencing run, including the
image analysis, base calling, and alignment. Alignment was
Figure 5. Schematic depiction of the neurotrophin signaling pathway. Those gene indicated in red represent genes upregulated in
expression and those in green, downregulated in expression, in response to Bcl11b. Figure generated using Pathway Design by Ingenuity Systems
Pathways Analysis. Abbreviations for the official gene symbols as follows: BDNF, Bdnf; NGF, Ngfb; PI3K, Pik3r1; GAB1, Gabl1; SHC, Shc1; PLCc1, Plcg2;
Ras, Kras; SOS, Sos1; SHP2, Ptpn11; MKK4/7, Map2k7; MEK, Map2k1; RSK, Rps6ka1; c-fos, Fos; Atf3, Atf3.
doi:10.1371/journal.pone.0023691.g005
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Databases (ELAND2). The uniquely aligned reads containing less
than 3 errors to the mouse genome are used as input to the Model-
based Analysis for ChIP-Seq (MACS) program, a publicly
available open source ChIP-Seq analysis (http://liulab.dfci.
harvard.edu/MACS/) [29]. Peaks found by MACS (v1.4alpha2)
were mapped to within 10 kb of a RefSeq transcript of the mouse
version mm9 database. The peak coordinates were then positioned
outside the 59 or 39 transcript coordinates, or within exons/introns
coordinates for the annotated genes, by comparing to the
transcript and exon start/end positions from the UCSC Genome
Browser. The peak sequences were obtained from queries to the
NCBI Entrez database using the chromosome coordinates.
DNA Motif Analysis
De novo motif finding was performed using MEME [15] on all of
the top ChIP-seq binding hits for Bcl11b (Table S3) and on the
subset of hits from the 59 region. On the two sets, MEME was run
both with default parameters and with the minimum number of
targets for each motif equal to the number of sequences in the
respective set. For each run, the top 5 motifs were retained,
obtaining a total of 20 putative motifs. MotifMap [16] was used to
filter this set of putative motifs by comparative genomic
conservation. The current version of MotifMap for the mouse
genome uses the multiple alignment of 30 model organisms’
genomes, downloaded from the UCSC genome browser [30], and
the corresponding phylogenetic tree to score the degree of
conservation of putative transcription factor binding sites using
the Bayesian Branch Length Score (BBLS).
A BBLS score .1 denotes a significant level of conservation
across a non-trivial subset of organisms in the reference tree;
values .2 denote a high level of conservation. The putative motifs
detected with MEME were filtered by selecting only those for
which at least four distinct ChIP-seq hits obtained a BBLS score
.1.
Detection of already annotated motifs was performed using all
(over 800) mouse transcription factors in the TRANSFAC 11.3
database [17]. The log-odd TRANSFAC motif matrices were used
to select those regions in the ChIP-seq hits with a Z-score p-value
less than 0.001. The background mean and standard deviation for
each motif-matching score were obtained by random sampling 10
millions locations in non-repeat regions of the mouse genome. As
above, each single motif-match was validated with MotifMap and
only those motifs for which at least four ChIP-seq hits obtained a
BBLS score .1 were retained (Table 2).
Real-Time PCR Analysis
Real-time PCR analysis was performed on the recovered DNA
from the ChIP experiments using primers directed against the
promoter regions of striatal-enriched genes (Table S5) or on cDNA
prepared from striatal cells using the primers designed in the
exonic regions of selected genes (Table S5) as described previously
[6,31]. Primers were designed to generate amplicons of 80–150
nucleotides with similar melting temperatures (64uC) using
Invitrogen’s Primer Designer.
Supporting Information
Figure S1 CNS Expression of Bcl11b. In situ hybridization
analysis was performed on free-floating coronal (A–F) and sagittal
sections (G) (25 mm-thick) from wild type C57black6J mice (2
months of age). Antisense
35S-labeled riboprobes directed against
Bcl11b were hybridized to brain sections as described previously
(Desplats et al., 2008). CPu, caudate putamen; Cx, cortex; Hipp,
hippocampus; Thal, thalamus; Cb, cerebellum; OT, olfactory
tubercle.
(PDF)
Figure S2 STHdh striatal cells express several markers
of mature medium spiny neurons, as indicated by their
official UniGene IDs below. Each gene was amplified from
cDNA prepared from RNA from duplicate wells of STHdh striatal
cells using standard PCR conditions.
(PDF)
Figure S3 Venn diagram showing overlap of Bcl11b
microarray gene expression and ChIP-seq data. Gene
expression changes at p,0.05 were used for the Venn overlaps.
(PDF)
Table S1 List of genes differentially expressed in
Bcl11b-transfected STHdh striatal cells compared to
mock (pcDNA3.1)-transfected cells.
(XLSX)
Table S2 Annotated ChIP-seq binding hits for Bcl11b in
STHdh striatal cells.
(XLSX)
Table S3 Functional Annotation Clustering analysis of
the integrated Bcl11b target genes (those appearing in
both microarray and ChIP-seq datasets) using The
Database for Annotation, Visualization and Integrated
Discovery (DAVID) software v6.7. The p-values associated
with each annotation are according to the Fisher Exact/EASE
Score.
(XLSX)
Table S4 Pathways analysis of integrated Bcl11b target
genes (those appearing in both microarray and ChIP-seq
datasets) using The Database for Annotation, Visualiza-
tion and Integrated Discovery (DAVID) v6.7 software,
focusing on PANTHER and KEGG databases. The p-values
reflect the threshold of EASE Score, a modified Fisher Exact P-
Value, for gene-enrichment analysis.
(XLSX)
Table S5 Primers used for quantitative real-time PCR
analysis and for ChIP-qPCR analysis. The ChIP-qPCR
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